La pseudodemenza: Aspetti clinici e terapeutici

Nuova Rivista di Neurologia

Volumn 8, Issue 1, 1998, Pages

  Morocutti, Cristoforo ^a,b   Rossi, Paolo ^a   Morocutti, Antonino ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

Aging; Antidepressant therapy; Depression; Pseudodementia

Indexed keywords

EID: 11744325289     PISSN: 1122035X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (109)

1. Aguglia E., Casacchia M., Cassano G.B., Faravelli L., et al.: Double blind study of the efficacy and safety of sertraline versus fluoxetine in major depression. Int. Clin. Psychopharmacology, 1993; 8:197-202.
2. Alexopoulos G.S., Young R.C., Myers B.S., et al.: Psychosis and depression in the elderly. Psychiatr. Clin. North. Am., 1988; 11: 215-221.
3. Alexopoulos G.S., Meyers B.S., Young R.C., Mottis S., Kakuma T.: The course of geriatric depression with reversible dementia: a controlled study. Am. J. Psychiatry, 1993;150:1693-1699.
4. Alexopoulos G.S., Young R.C., Meyers B.S.: Geriatric depression: age of onset and dementia. Biol. Psychiatry, 1993; 34:141- 145.
5. American Psychiatric Association: Diagnostic and statistical manual of mental disorders. 3rd edition revised, DSM III-R. Washington DC.
6. Arie T.: Pseudodementia. Br. Med. J., 1983;64:1301-1302.
7. Ashford W., Ford C.V.: Use of monoamine oxidase inhibitors in elderly patients. Am. J. Psychiatry, 1979; 136:1460-1465.
8. Baldwin B.: Late life depression: undertreated ? Brit. Med. J. 1988; 196:519-525.
9. Beasley C.M. Jr, Dornseif B.E., Pultz J.A., Bosomworth J.C., Sayler M.E.: Fluoxetine versus trazodone: efficacy and activating-sedating effects. J. Clin. Psychiatry. 1991; 52:294-299.
10. Blazer D.G.: Depression in the elderly. N. Engl. J. Med., 1989; 320:164-166.
11. Blazer D.G., Bacher J.R., Montan K.G.: Suicide in late life; review and commentary. J. Am. Geriatr. Soc., 1986; 34:519-525.
12. Blazer D.G., Burchett B., Service C., George L.K.: The association of age and depression among the elderly: an epidmiologic exploration. J. Gerontol., 1991; 46: M210-M215.
13. Blazer D.G., Hughes D.C., George L.K.: The epidemiology of depression in an elderly community population. Gerontologist., 1987; 27:281-287.
14. Brodaty H., Luscambe G.: Depressions in persons with dementia. Int. Psychogeriatr., 1996; 8:609-622.
15. Buntinks F., Kester A., Bergers J., Knottneur S.: Is depression in elderly people followed by dementia? A retrospective cohort study based on general practice. Age ageing, 1996; 25:231-233.
16. Burke W.J., Dewan V., Wengel S.P., et al.: The use of selective serotonin reuptake inhibitor for depression and psychosis complicating dementia. Int. J. Geriatr. Psychiatry, 1997; 12:519-525.
17. Byerly M.J., Goodman W.K., Christensen R.: High doses of sertraline for treatment of resistant obsessive-compulsive disorder. Am. J. Psychiatry, 1996; 153:1232-1233.
18. Caine E.D.: Pseudodementia. Current concepts and future directions Arch. Gen. Psychiatry, 1981; 38:1359-1364.
19. Carpenter L.L., McDougle C.J., Epperson C.N., Price L.H.: A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder. Drug. Saf., 1996; 15:116-134.
20. Cassem N.H.: Cardiovascular effects of antidepressants. J. Clin. Psychiatry, 1982; 43:22-28.
21. Clarfield A.M.:The reversible dementia: do they reverse? Ann. Intern. Med., 1988; 109:476-486.
22. Cohn C.K.: 5HT antidepressants in the elderly: a 10 years experience. In:Bergener and Belmaker, Eds., Psychopharmacotherapy for the elderly: principles of research and clinical implication. Springer publishing company. New York, 1993; 328- 334.
23. Curran S.M., Murray C.M., Van Beck M., et al.: A single photon emission computerised tomography study of regional brain function in elderly patients with major depression and Alzheimer-type dementia. Br. J. Psychiatry. 1993; 163:155-165.
24. Davis J.M., Glassman A.H.: Antidepressant drug. In:Kaplan HI, Sadock BJ, Eds., Comprehensive textbook of Psychiatry. 5th edition, Williams and Wilkins, Baltimore. 1989; 1627-1655.
25. DeBeavouir S.: The coming of age. Editions Gallimard, Paris, 1970.
26. Emery V.O., Oxman T.E.: Update on dementia spectrum of depression. Am. J. Psychiatry, 1992; 149:305-317.
27. Epstein L.J.: Depression in the elderly. J. Gerontol., 1976; 31: 278-282.
28. Feinhert T., Goodman B.: Affective illness, dementia and psudodementia. J. Clin. Psychiatry, 1984; 45: 99-103.
29. Fredericks J.A.M.: Dementie. Ned Tdschr Geneesk. 1985; 129: 24-28.
30. Geffen G., Bate A., Wright M., Rozenbilds U., Geffen L.: A comparison of cognitive impairments in dementia of the Alzheimer type and depression in the elderly. Dementia, 1993; 4:294-300.
31. Gottrfies C.G., Karlsson I., Nyth A.L.: Treatment of depression in elderly patients with and without dementia disorders. Int. Clin. Psychopharmacol., 1992; 6 (Suppl 5): 55-64.
32. Grapperon J., Bruschera D., Vidal F., Raoul Y.: Can neurophysiologic tests differentiate between depression and dementia? Ann. Med. Psychol. (Paris), 1994; 152: 217-228.
33. Grunwald F., Horn R., Riecker O., et al.: HMPAO-SPECT in Alzheimer-type dementia and major depression with memory impairment. Nuklear Medizin., 1993; 32:128-133.
34. Gurland B.J.: The comparative frequency of depression in various adult age groups. J. Gerontol., 1976; 31:283-292.
35. Gurland B.J., Wilder D.E., Berkman C.: Depression and disability in the elderly: reciprocal relations and change with age. Int. J. Geriatr. Psychiatry, 1988; 3:163-179.
36. Gurwitz J.H., Avorn J.: The ambiguous relation between aging and adverse reaction. Am. Intern. Med., 1991; 114:956-996.
37. Haase G.R.: Diseases presenting as dementia In:Wells CE. Ed. Dementia. FA Davis, Philadelphia, 1977; 26-44.
38. Henderson A.S., Montgomery I.M., Williams C.L.: Psychological immunisation: a proposal for preventive psychiatry. Lancet, 1972; 6:1111-1113.
39. Henderson A.S.: Does aging protect against depression? Soc. Psychiatry Epidemiol., 1994; 29:107-109.
40. Hill C.D., Stoudemire A., Morris R., Martino- Saltzman D., et al.: Dysnomia in the differential diagnosis of major depression, depression-related cognitive dysfunction and dementia. J. Neuropsychiatry Clin. Neurosci., 1992; 4:64-69.
41. Jellinger K : Neuropathological aspects of dementia resulting from abnormal blood and cerebrospinal fluid dynamics. Acta Neurol. Belg., 1976; 76:88-102.
42. Jenike M.A.: The use of monoamine oxidase inhibitors in elderly depression patients. J. Am. Geriatr. Soc., 1984;32:571-575.
43. Jenike M.A.: Assessment and treatment of affective illness in the elderly. J. Geriatr. Psychiatry Neurol., 1988; 1:89-107.
44. Katzman R.: The prevalence and malignancy of Alzheimer disease. Arch. Neurol., 1976; 33:217-218.
45. Katzman R.: Alzheimer's disease. N. Engl. J. Med., 1986; 314: 964-973.
46. Katzman R., Lasker B., Bernstein N.: Advances in the diagnosis and consequences of misdiagnosis of disorders causing dementia In:Terry R.D. Ed. Aging and the brain. Raven Press, New York, 1988, vol. 32, 17-62.
47. Katzman R., Kowas C.: The evolution of the diagnosis of Dementia: past, present and future. In:Poeck K., Freund H.J. Eds., Neurology: the clinical aspects of dementias. Springer Verlag, Berlin/Heidelberg, 1989; 43-49.
48. Katzman R., Terry R.W.: The Neurology of aging. FA Davis, Philadelphia, 1992.
49. Kielholz P.: Clinique, diagnostic differentiel et traitment des etats depressifs. Acta Psychosom. Geigy SA, Bale, 1959.
50. Kilon L.G.: Pseudodementia. Acta Psychiatr. Scand., 1961; 37: 336-351.
51. Kronig M.H., Roose S.P., Walsh B.T., et al.: Blood pressure effects of phenelzine. J. Clin. Psychopharmacol., 1983;3:307-312.
52. Kumar A.: Functional brain imaging in late life depression and dementia. J. Clin. Psychiatry, 1993; 545:21-25.
53. Lachner G., Engel R.R.: Differentiation of dementia and depression by memory tests. A meta-analysis. J. Nerv. Ment. Dis., 1994; 182:34-39.
54. Laizure S.C., Devane C.L., Stewart J.T., Dommisse C.S., Lai A.A.: Pharmacokinetics of bupropion and its major basic metabolites in normal subjects after a single dose. Clin. Pharmacol. Ther., 1985; 38:586-589.
55. Larson E.B., Reifler B.V., Sum J.M.,Clarfield G.G.,Chinn N.M.: Diagnostic evaluation of 200 elderly outpatients with suspected dementia. J. Gerontol., 1985;40:536-543.
56. Lehtinen V., Joukamaa M., Lahtele K., Rajstado R., Jyrkinen E., Maatel J.: Prevalence of Mental disorders among adults in Finland: basic results from the Mini Finland Survey. Acta Psychiatr. Scand., 1990; 81:418-425.
57. Lundquist R.S., Bernens A., Olsen C.G.: Comorbid disease in geriatric patients: dementia and depression. Am. Fam. Physician., 1997; 55:2687-2694.
58. Lydiard R.B., Obsessive-compulsive disorder: a new perspective in diagnosis and treatment. Int. Clin. Psychopharmacol., 1994;9 (S3):33-37.
59. Madden J.J., Luhan J.A., Kaplan L.A.: Non dementing psychoses in older persons. JAMA, 1952; 150:1567-1570.
60. Marsden C.D.: Assessment of Dementia. In:Vinken P.J., Bruyn J.W., Eds, Handbook of Clinical disorders. Elsevier Science Publishers, North-Holland Amsterdam, 1985, vol. 46, 221-223.
61. Marsden C.D.: The diagnosis of dementia. In:Isaacs A.D. Post F. Eds., Studies in Geriatric Psychiatry. John Kiley, Chichester, 1978, 95-118.
62. McAllister T.W., Price T.R.P.: Severe depressive pseudodementia with and without dementia. Am. J. Psychiatry, 1982;139:626- 629.
63. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadean E.M.: Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work groups under the auspices of department of health and human services task force on Alzheimer's disease. Neurology, 1984; 34:939-944.
64. Montgomery S.A.: Long term management of obsessive-compulsive disorder. Int. Clin. Psychopharmacol., 1996; 11:(S5):23- 29.
65. Murphy E.I.: The prognosis of depression in old age. Br. J. Psychiatry, 1983; 142:111-119.
66. Murrel S.A., Himmelforh S., Wright K.: Prevalence of depression and its correlates in older adults. Am. J. Epidemiol., 1983; 117:173-185.
67. Nelson J.C.: Current status of tryciclic antidepressants in psychiatry: their pharmacology and clinical applications. J. Clin. Psychiatry. 1991; 52:193-200.
68. Newman J.P.: Aging and Depression. Psychology Aging, 1989; 4: 150-165.
69. Nielsen J.: Geronto-Psychiatric period-prevalence investigation in a geographically delimited population. Acta Psychiatr. Scand., 1963; 38:307-330.
70. NIH consensus development panel on depression in late life. Diagnosis and treatment of depression in Late life. JAMA, 1992; 268:1018-1024.
71. Nott P., Flemings J.: Presenile dementia: the difficulty of early diagnosis. Acta Psychiatr. Scand., 1975; 51:210-217.
72. O'Brien J.T., Desmond P., Ames D., Schweitzer I., et al.:The differentiation of depression from dementia by temporal lobe magnetic resonance imaging. Psychol. Med., 1994;24:633-640.
73. O'Hara M.W., Kohaut F.S., Wallace R.B.: Depression among the rural elderly: a study of prevalence and correlates. J. Nerv. Mental Dis., 1985; 173:582-589.
74. Palinkas L. A., Wingard D.L., Burret-Connor E.: Chronic illness and depressive symptoms in the elderly: a population based study. J. Clin. Epidemiol., 1990; 43:1131-1141.
75. Perez Stable E.J., Miranda J., Munoz R.F., Ying Y.W.: Depression in medical outpatients: underrecognition and misdiagnosis. Arch. Intern. Med., 1990; 150:1083-1088.
76. Pontel J., Schroeder J., Essig M., Popp D., et al.: Quantitative Magnetic Resonance Imaging in geriatric depression and primary degenerative dementia. J. Affect. Disord.. 1997;42:69-83.
77. Post F.: The management and nature of depressive illnesses in late life: a follow-through study. Br. J. Psychiatry., 1972;121:393- 404.
78. Post F.: Dementia, depression and pseudodementia. In:Benson D.E. Blumer D., Eds., Psychiatric aspects of neurologic disease. Grune and Stratter, New York, 1975, vol. 1; 99-120.
79. Preskorn J.H.: Tryciclic antidepressants; the whys and hows of therapeutic drug monitoring. J. Clin. Psychiatry, 1989; 56 (suppl.): 34-42.
80. Preskorn J.H., Burke M.: Somatic therapy for major depression disorder: selection of an antidepressant. J. Clin. Psychiatry, 1992;53S: 1-14.
81. Preskhorn J.H.: Recent pharmacologic advances in antidepressants therapy for the elderly. Am. J. Med., 1993:, 94 (5A):2s-12s.
82. Ravizza L.: La depressione nell'invecchiamento. In:Cassano G.B. Ed., Psichiatria Medica. UTET, Torino, 1990:237-247.
83. Regier D.A., Farmer M.E., Rae D.S., Myers J.K., Kramer M., Robins L.N.: One month prevalence of mental disorders in the United States and Socio demographic characteristics: the Epidemiology Catchement Area Study. Acta Psychiatr. Scand., 1993;88:35-47.
84. Reifler B., Larson E., Hanley R.: Coexistence of cognitive impairment and depression in geriatric patients. Am. J. Psychiatry, 1982; 139:623-626.
85. Ricke B.K., Schweizer E.: Clinical overview of serotonin reuptake inhibitors. J. Clin. Psychiatry, 1990; 51:9-12.
86. Rocca W. A., Amaducci L. A., Schoenberg B.S.: Epidemiology of clinically diagnosed Alzheimer's disease. Ann. Neurol., 1986; 19:415-424.
87. Ron M.A., Toone B.K., Garralda M.E., Lishman W.A.: Diagnostic accuracy in presenile dementia. Br. J. Psychiatry, 1979; 134:161-168.
88. Roth M.: Epidemiological studies. In:Katzman R., Terry R.D., Bick K.L., Eds, Alzheimer's disease: senile dementia and related disorders. Aging. Raven Press, New York, 1978, vol 7, 33-339.
89. Rowe J.W., Kahn R.L.: Human aging: usual and successful. Science, 1987; 237:143-149.
90. Rudorfer M.V., Potter W.Z., Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the newer versus the older drugs. Drugs, 1989; 37:713-738.
91. Schwab J.J., Halzer C., Warheit G.J.: Depressive symptomatology and age. Psychosomatics, 1973; 14:135-141.
92. Seavern A.W., Kilmam P.R.: Status of ECT: a review of the outcome literature. Psychol. Bull., 1980; 87:260-271.
93. Seltzer B., Sherwin I.: Organic brain syndromes; an empirical study and critical review. Am. J. Psychiatry, 1978; 135:13-21.
94. Sendhuerler J., Goldsteins A.: Attempted suicide among the aged. J. Am. Geriatr. Soc., 1977; 25:245-248.
95. Shamoian C.A.: Assessing depression in elderly patients. Hosp. Comm. Psychiatry, 1985; 36: 328-339.
96. Sheenan D.V., Claylamb J.B., Koretos N.: Monoamine oxidase inhibitors; prescription and patient management. Int. J. Psychiatry Med., 1980; 10:94-100.
97. Shraberg D.: The myth of pseudodementia: depression and the aging brain. Am. J. Psychiatry, 1978; 135:601-605.
98. Swartz J.R., Miller B.L., Lesser I.M., Booth R., et al: Behavioral phenomenology in Alzheimer's disease, frontotemporal dementia and late-life depression; a retrospective analysis. J. Geriatr. Psychiatr. Neurol., 1997; 10:67-74.
99. Tomlinson B.E., Blessed G., Roth M.: Observation of the brain of demented old people. J. Neurol. Sci., 1970; 11:205-242.
100. United Nations. Department of Economical and Social affair. Selected demographic indicators by country 1950-2000; demographic estimations and projections as assessed in 1978. United Nations. New York, 1980.
101. Wells C.E.: Pseudodementia. Am. J. Psychiatry, 1979;136:895-900.
102. Wells C.E.: Diagnosis of dementia. Psychosomatics, 1979; 20: 517-530.
103. Wells K.B., Stewart A., Hays R.D., et al: The functioning and well being of depressed patients: results from the Medical Outcome Study. JAMA, 1989; 262:914-919.
104. Winstead D.K., Mielke D.H., O'Neill P.T.: Diagnosis and treat- ment of depression in the elderly: a review. Psychiatry Med., 1190; 8:85-98.
105. Wittchen H.U., Knauper B., Kessler R.L.: Depression across the life cycle. Br. J. Psychiatry, 1984; 144:112-116.
106. Wragg R.E., Jeste D.V.: Overview of depression and psychosis in Alzheimer's disease. Am. J. Psychiatry, 1985; 146:577-588.
107. Wurthmann C., Bogerts B., Falkai P.: Brain morphology as- sessed by computed tomography in patients with geriatric depression, patients with degenerative dementia and normal control subjects. Psychiatry Res., 1995; 61:103-111.
108. Yesavage J.: Differential diagnosis between depression and dementia. Am. J. Med., 1993; 94(5A): 23S-28S.
109. Zung W.W.: Depression in the normal aged. Psychosomatics, 1968; 8:287-292.